Skip to Main content Skip to Navigation
Journal articles

COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave

Stéphane Bretagne 1, 2, 3 Karine Sitbon 1, 2 Françoise Botterel 4 Sarah Dellière 1, 2, 3 Valérie Letscher-Bru 5 Taieb Chouaki 6 Anne-Pauline Bellanger 7 Christine Bonnal 8 Arnault Fekkar 9, 10 Florence Persat 11 Damien Costa 12 Nathalie Bourgeois 13 Frédéric Dalle 14 Florian Lussac-Sorton 15 André Paugam 16 Sophie Cassaing 17 Lilia Hasseine 18 Antoine Huguenin 19 Nadia Guennouni 20, 21 Edith Mazars 22 Solène Le Gal 23 Milène Sasso 24 Sophie Brun 25 Lucile Cadot 26 Carole Cassagne 27 Estelle Cateau 28 Jean-Pierre Gangneux 29 Maxime Moniot 30 Anne-Laure Roux 31, 32 Céline Tournus 33 Nicole Desbois-Nogard 34 Alain Le Coustumier Olivier Moquet 35 Alexandre Alanio 1, 2, 3 Françoise Dromer 1
Abstract : The aim of this study was to evaluate diagnostic means, host factors, delay of occurrence, and outcome of patients with COVID-19 pneumonia and fungal coinfections in the intensive care unit (ICU). From 1 February to 31 May 2020, we anonymously recorded COVID-19-associated pulmonary aspergillosis (CAPA), fungemia (CA-fungemia), and pneumocystosis (CA-PCP) from 36 centers, including results on fungal biomarkers in respiratory specimens and serum. We collected data from 154 episodes of CAPA, 81 of CA-fungemia, 17 of CA-PCP, and 5 of other mold infections from 244 patients (male/female [M/F] ratio = 3.5; mean age, 64.7 ± 10.8 years). CA-PCP occurred first after ICU admission (median, 1 day; interquartile range [IQR], 0 to 3 days), followed by CAPA (9 days; IQR, 5 to 13 days), and then CA-fungemia (16 days; IQR, 12 to 23 days) (P < 10-4). For CAPA, the presence of several mycological criteria was associated with death (P < 10-4). Serum galactomannan was rarely positive (<20%). The mortality rates were 76.7% (23/30) in patients with host factors for invasive fungal disease, 45.2% (14/31) in those with a preexisting pulmonary condition, and 36.6% (34/93) in the remaining patients (P = 0.001). Antimold treatment did not alter prognosis (P = 0.370). Candida albicans was responsible for 59.3% of CA-fungemias, with a global mortality of 45.7%. For CA-PCP, 58.8% of the episodes occurred in patients with known host factors of PCP, and the mortality rate was 29.5%. CAPA may be in part hospital acquired and could benefit from antifungal prescription at the first positive biomarker result. CA-fungemia appeared linked to ICU stay without COVID-19 specificity, while CA-PCP may not really be a concern in the ICU. Improved diagnostic strategy for fungal markers in ICU patients with COVID-19 should support these hypotheses. IMPORTANCE To diagnose fungal coinfections in patients with COVID-19 in the intensive care unit, it is necessary to implement the correct treatment and to prevent them if possible. For COVID-19-associated pulmonary aspergillosis (CAPA), respiratory specimens remain the best approach since serum biomarkers are rarely positive. Timing of occurrence suggests that CAPA could be hospital acquired. The associated mortality varies from 36.6% to 76.7% when no host factors or host factors of invasive fungal diseases are present, respectively. Fungemias occurred after 2 weeks in ICUs and are associated with a mortality rate of 45.7%. Candida albicans is the first yeast species recovered, with no specificity linked to COVID-19. Pneumocystosis was mainly found in patients with known immunodepression. The diagnosis occurred at the entry in ICUs and not afterwards, suggesting that if Pneumocystis jirovecii plays a role, it is upstream of the hospitalization in the ICU.
Complete list of metadata
Contributor : Hal Sorbonne Université Gestionnaire Connect in order to contact the contributor
Submitted on : Tuesday, October 26, 2021 - 4:46:15 PM
Last modification on : Wednesday, January 19, 2022 - 5:42:02 PM


Publication funded by an institution



Stéphane Bretagne, Karine Sitbon, Françoise Botterel, Sarah Dellière, Valérie Letscher-Bru, et al.. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave. Microbiology Spectrum, American Society for Microbiology, 2021, 9 (2), pp.e0113821. ⟨10.1128/Spectrum.01138-21⟩. ⟨hal-03404538⟩



Les métriques sont temporairement indisponibles